Anti-POMGNT2 antibodies are used in the immunodetection of the protein protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-). In humans, the canonical protein has a reported length of 580 amino acid residues and a mass of 66.6 kDa. Its subcellular localization is in the ER. It is reported to be highly expressed in the brain, muscle, heart, and kidney in both fetus and adult. It is a member of the Glycosyltransferase 61 protein family. Post-translational modifications have been described, including glycosylation. The POMGNT2 gene has been associated with the disease, Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies. Synonyms for this target antigen include glycosyltransferase-like domain containing 2, glycosyltransferase-like domain-containing protein 2, protein O-mannose beta-1,4-N-acetylglucosaminyltransferase 2, and protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2. POMGNT2 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. Western Blot is a widely used application for the POMGNT2 antibodies listed below. In addition, Immunofluorescence is also a common application.